A Phase II study of the safety, pharmacokinetics and efficacy of IncelTM (biricodar, VX-710) in combination with mitoxantrone (M) and prednisone (P) in advanced hormone refractory prostate cancer (HRPC)
1999 ◽
Vol 35
◽
pp. S349
◽
Keyword(s):
Phase Ii
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 16027-16027